Spirometry (Pulmonary Function Tests)

1. Spirometry (Pulmonary Function Tests) By: • H. Mehrparvar, M.D. Yazd University of Medical Sciences

2. Definition A physiological test for measuring volumes inhaled or exhaled by an individual as a function of time

3. Indications • Not a screening test for general population • Diagnostic • Monitoring • Impairment evaluation • Public health

4. Indications (diagnostic) • Evaluation of symptoms and signs • Measuring the effect of dis. on pulmonary function • Screening individuals at risk for pulmonary dis. • Assess preoperative risk • Assess health status before physical activities (e.g. work)

5. Indications (monitoring) • Assess therapeutic intervention • Monitor people exposed to injurious agents

6. Spirometry standards • ATS (American Thoracic Society) • ERS (European Respiratory Society)

7. Spirometry maneuvers • FVC • VC and IC • PEF • MVV

8. FVC maneuver • Requirements of spirometer: • Accumulating volume for at least 15 s • Measuring volumes at least 8 lit • Accuracy of at least ± 3% or ±0.050 lit with flows between 0 and 14 lit/s • Showing both volume-time and flow-volume curves • Showing EV value

9. Test procedure • Maximal inspiration • A blast of exhalation • Complete exhalation to the end of test

10. Spirometry curves

11. Contraindications of Spirometry • Uncontrolled hypertension • Suspected presence of active TB or other communicable respiratory disease • Thoracic or abdominal surgery within recent 3 wks • MI or unstable angina within recent 6 wks • Respiratory distress • Active hemoptysis • Recent eye/ear surgery • Abdominal or thoracic aortic aneurysm

12. Interfering condition • Acute illness or cold during the past few days • Any respiratory infection during the past 3 weeks • Heavy meal during the past 1-2 hour • Cigarette smoking during the past 1 hour

13. Spirometric indices • FVC (forced vital capacity) • FEV1 (forced expiratory volume in 1 s) • FEV1/FVC • FEVt (forced expiratory volume in t s) • FEF25-75 (maximum mid-expiratory flow) • PEF (peak expiratory flow)

14. FVC • Definition: • maximal amount of air that can be exhaled forcefully after a maximal inspiration or the most air a person can blow out after taking the deepest possible breath.

15. FEV1 • Definition: • The volume of air exhaled during the first second of a forced expiratory maneuver

16. FEV1/FVC% • Definition: • The value expresses the volume of air the worker exhales in one second as a percent of the total volume of air that is exhaled.

19. Spirometry Performance Steps • Equipment performance criteria • Equipment quality control ( calibration & leak ) • Contraindications & interfering condition • Age, height, race, gender • Selection of appropriate reference value • Patient maneuver • Acceptability criteria • Reproducibility criteria • Selection of best curve and best result • interpretation

20. Within maneuver evaluation • Start of test criteria - back extrapolation(EV < 5% of FVC or 150 ml) ● End of test criteria - the subject cannot or should not continue - exhalation at least 6s (in children under 10, 3s) - no change in volume (<0.025 lit) for at least 1s * In obstruction or older subjects more than 6s exhalation (till 15s)

21. Acceptability ● Start of test criteria ● End of test criteria ● cough especially during first second ● Valsalva maneuver (glottis closure) ● Leak from the mouth ● Obstruction of the mouthpiece ● Extra breath during the maneuver

23. Repeatability • At least three acceptable maneuvers Maximum difference between the largest and next largest FVC and FEV1 = 150ml (If FVC <1lit, this value is 100ml) ● At the most eight tests should be performed

24. Flow chart of criteria

25. Reversibility testing • Stop drugs (short-acting for 4 h, long-acting for 12h) before test • Stop smoking for 1 h. before test • Perform baseline test • Administer drug • Perform test after 10 – 15 min. (for salbutamol) or after 30 min. (for ipratropium)

26. Reversibility criteria 1. VC (forced or slow) and FEV1the primary indices for bronchodilator response. 2. A 12% increase, and a 200-ml increase in either FVC or FEV1 3. FEF25-75 should be used secondarily in evaluating bronchodilator response. 4. Ratios such as FEV1/VC should not be used to judge bronchodilator response.

27. VC maneuver • Two types (IVC and EVC) • Perform this test prior to FVC • Perform not more than 4 tests (at least 1 min. apart) • Surely use nose clip

28. Measuring lung volumes (RV, FRC, TLC) • Nitrogen washout • Helium dilution • Body plethysmography • Diffusing Capacity

29. Interpretation

30. Key Notes 1. Be conservative in suggesting a specific diagnosisbased only on pulmonary function abnormalities. 2. Interpretborderline normal values with caution. 3. First step = to evaluate and comment on the quality of the tests.

31. Key Notes 4. The number of test indices (e.g., FVC, FEV1, etc.) used in interpretation shouldbe limited to avoid an excessive number offalse positive results. 5. The primary guides for spirometryinterpretation should be VC (slow or forced), FEV1, and FEV1/VC. 6. FEV1/VC should be the primary guide fordistinguishing obstructive from nonobstructive patterns.

32. Key Notes 7. If FEV1/VC is borderline, use Instantaneous and mid flows to confirm airway obstruction. 8. Don’t use FEF25-75 and the instantaneous flows to diagnose small airwaydisease. 9. The pattern of a low FEV1/VC and greater than average VC and FEV1 should be recognized as one that may occur inhealthy individuals.

33. Key Notes 10. The severity of airway obstruction shouldbe based on FEV1. 11. When FEV1 and FEV1/VC arenormal, don’t use FEF25-75 for grading the severity of obstruction. 12. A reducedVC and normal FEV1/VC suggest but not diagnose the presence of restriction. 13. The severity of restriction should be based on TLC. If VC is used, severity may be based on VC.

34. Lower Limits of Normal 1. Normal ranges should be based on calculated fifth percentiles. 2. Lower limits of normal are variable. 3. The use of 80% of predicted for adult pulmonary function parameters is not recommended. This criterion works only for average persons and for a limited number of parameters.

35. LLN • FEV1 and FVC = 80% • FEV1/FVC = 70-75% • FEF25-75 = 50-60%

37. Interpretation A. Normal: both the VC and the FEV1/VC ratio are normal. B. Obstructive: FEV1/VC ratio is below the normal range. The severity of the abnormality is graded: - % Pred FEV1 > 100 = May be a physiological variant - % Pred FEV1 < 100 and > 70 = Mild - % Pred FEV1 < 70 and > 60 = Moderate - % Pred FEV1 < 60 and > 50 = Moderately severe - % Pred FEV1 < 50 and > 34 = Severe - % Pred FEV1 < 34 = Very severe

38. Interpretation C. Restrictive: This is most reliably interpreted on the basis ef TLC. If this is not available,one may interpret a reduction in the VC without a reduction of the FEV1/VC ratio as a restriction The severity of the abnormality might be graded as follows: -% Pred VC < LLN and > 70 = mild - % Pred VC < 70 and > 60 = Moderate • % Pred VC < 60 and > 50 = Moderately severe • % Pred VC < 50 and > 34 = Severe - % Pred VC < 34 = Very severe

41. Case 1 • A 60 year old man with a 60 pack/year smoking history and dyspnea on exertion • FVC =73%, FEV1 = 23% FEV1/FVC = 25% FEF25-75 = 6%TLC = 150% DLCO = 19%

42. Answer • This patient has emphysema. His FEV1/FVC ratio is < 70% which indicates obstruction. His FEV1 is < 34% of predicted which indicates very severe obstruction. His TLC is elevated and his diffusing capacity is very low. We consider PFTs consistent with emphysema if there is (1) non-reversible obstruction, (2) elevated lung volumes, (3) low diffusing capacity, and (4) an adequate smoking history

43. Case 2 • 50 year old man with a 65 pack/year smoking history and a cough. His chest x-ray shows a diffuse reticulonodular pattern • FVC =62%, FEV1 = 42% FEV1/FVC = 56% FEF25-75 = 11%TLC = 64% DLCO = 29%

44. Answer • First, he is obstructed because the FEV1/FVC ratio is < 72%. Second, he is restricted since the TLC is < 80%. Third, he has a low diffusing capacity. The differential diagnosis of combined restrictive & obstructive defects includes cystic fibrosis, bronchiectasis, lymphangioleimomatosis, eosinophilic granuloma, and interstitial disease + COPD. This patient has eosinophilic granuloma

45. Case 3 • A 22 year old woman with dyspnea on exertion. She also notes dyspnea when exposed to cats. On physical exam, she is wheezing • FVC =83%, FEV1 = 60% FEV1/FVC = 61% FEF25-75 = 23%TLC = 100% DLCO = 122%

46. Answer • This is pretty typical for asthma. The FEV1/FVC ratio is < 75% so she is obstructed. The FEV1 puts her in the moderate obstruction category. She is not restricted and the diffusing capacity is increased. The reason why the diffusing capacity is increased in asthma is not fully known but it has been suggested that there is increased pulmonary blood flow, allowing increased carbon monoxide extraction from the carbon monoxide inhalation.

47. Case 4 • 43 year old woman with progressive dyspnea on exertion. Chest x-ray shows bilateral reticular infiltrates, especially in the lung bases • FVC =51%, FEV1 = 49% FEV1/FVC = 78% FEF25-75 = 35%TLC = 52% DLCO = 51%

48. Answer • This is characteristic for interstitial lung disease. The FEV1/FVC ratio is > 73% so she is not obstructed. The TLC is 35% of predicted so she falls in the severe restriction category. The diffusing capacity is low indicating impairment to gas transport